<VariationArchive VariationID="30873" VariationName="NM_024306.5(FA2H):c.510_511del (p.Tyr170_Ser171delinsTer)" VariationType="Deletion" Accession="VCV000030873" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2015-05-13" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39830" VariationID="30873">
      <GeneList>
        <Gene Symbol="FA2H" FullName="fatty acid 2-hydroxylase" GeneID="79152" HGNC_ID="HGNC:21197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74712969" stop="74774820" display_start="74712969" display_stop="74774820" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74746852" stop="74808728" display_start="74746852" display_stop="74808728" Strand="-" />
          </Location>
          <OMIM>611026</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024306.5(FA2H):c.510_511del (p.Tyr170_Ser171delinsTer)</Name>
      <CanonicalSPDI>NC_000016.10:74726326:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="74726327" stop="74726328" display_start="74726327" display_stop="74726328" variantLength="2" positionVCF="74726326" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="74760225" stop="74760226" display_start="74760225" display_stop="74760226" variantLength="2" positionVCF="74760224" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.74726328_74726329del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.74726328_74726329del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.74760226_74760227del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.74760226_74760227del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017070.1" sequenceAccession="NG_017070" sequenceVersion="1" change="g.53504_53505del">
            <Expression>NG_017070.1:g.53504_53505del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024306.5" sequenceAccession="NM_024306" sequenceVersion="5" change="c.510_511del" MANESelect="true">
            <Expression>NM_024306.5:c.510_511del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_077282.3" sequenceAccession="NP_077282" sequenceVersion="3" change="p.Tyr170_Ser171delinsTer">
            <Expression>NP_077282.3:p.Tyr170_Ser171delinsTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA259931" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611026.0006" DB="OMIM" />
        <XRef Type="rs" ID="587776891" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024306.5(FA2H):c.510_511del (p.Tyr170_Ser171delinsTer) AND Hereditary spastic paraplegia 35" Accession="RCV000023858" Version="7">
        <ClassifiedConditionList TraitSetID="6693">
          <ClassifiedCondition DB="MedGen" ID="C3496228">Hereditary spastic paraplegia 35</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024306.5(FA2H):c.510_511del (p.Tyr170_Ser171delinsTer) AND Spastic paraplegia" Accession="RCV002513208" Version="2">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-05-13" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20853438</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23745665</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25496456</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25732363</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26344562</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31135052</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6693" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="4413" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 35</ElementValue>
                <XRef ID="Leukodystrophy%2C+dysmyelinating%2C+and+spastic+paraparesis+with+or+without+dystonia/4201" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 35, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 35</ElementValue>
                <XRef ID="MONDO:0012866" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION</ElementValue>
                <XRef Type="MIM" ID="612319" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611026.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukodystrophy, dysmyelinating, and spastic paraparesis with or without dystonia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG35</ElementValue>
                <XRef Type="MIM" ID="612319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10538" />
                <XRef ID="10538" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fatty acid hydroxylase-associated neurodegeneration (FAHN) is characterized early in the disease course by central nervous system involvement including corticospinal tract involvement (spasticity), mixed movement disorder (ataxia/dystonia), and eye findings (optic atrophy, oculomotor abnormalities), and later in the disease course by progressive intellectual impairment and seizures. With disease progression, dystonia and spasticity compromise the ability to ambulate, leading to wheelchair dependence. Life expectancy is variable. FAHN is considered to be a subtype of neurodegeneration with brain iron accumulation (NBIA).</Attribute>
                <XRef ID="NBK56080" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21735565</ID>
                <ID Source="BookShelf">NBK56080</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="171629" DB="Orphanet" />
              <XRef ID="C3496228" DB="MedGen" />
              <XRef ID="MONDO:0012866" DB="MONDO" />
              <XRef Type="MIM" ID="612319" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="50405" SubmissionDate="2021-11-24" DateLastUpdated="2021-11-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611026.0006_SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION" title="FA2H, 2-BP DEL, 509AC_SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION" />
        <ClinVarAccession Accession="SCV000045149" DateUpdated="2021-11-29" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Albanian brothers with a complicated form of autosomal recessive spastic paraplegia-35 (SPG35; 612319) and evidence of brain iron accumulation in the globus pallidus, Kruer et al. (2010) identified a homozygous 2-bp deletion (c.509_510delAC) in the FA2H gene, resulting in a frameshift and premature termination.</Attribute>
              <Citation>
                <ID Source="PubMed">20853438</ID>
              </Citation>
              <XRef DB="OMIM" ID="612319" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Donkervoort et al. (2014) identified homozygosity for the c.509_510delAC deletion in the FA2H gene, which resulted in a frameshift and a premature stop codon (Tyr170Ter), in a brother and sister from Montenegro with SPG35. The mutation segregated with the disorder in the family; functional studies were not performed. Both children had typical features of the disorder, but no brain iron accumulation was seen on brain MRI. Because this mutation had been identified by Kruer et al. (2010) in 2 brothers from Albania with a similar neurodegenerative disorder with brain iron accumulation, Donkervoort et al. (2014) suggested that it may represent a founder mutation in individuals from the Balkan region.</Attribute>
              <Citation>
                <ID Source="PubMed">23745665</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20853438</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FA2H" />
          </GeneList>
          <Name>FA2H, 2-BP DEL, 509AC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 509AC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611026.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131804" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4933068|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442363" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20853438</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25496456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25732363</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26344562</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20853438</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23745665</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31135052</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr170*) in the FA2H gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FA2H are known to be pathogenic (PMID: 20853438, 25496456, 25732363, 26344562). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of FA2H-related conditions (PMID: 20853438, 23745665, 31135052). This variant is also known as c.509_510delAC. ClinVar contains an entry for this variant (Variation ID: 30873). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FA2H" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.74760225_74760226del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6131804" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="50405" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION" MappingRef="Preferred">
        <MedGen CUI="C3496228" Name="Hereditary spastic paraplegia 35" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

